Skip to main content

Middle Meningeal Artery Embolization Feasible for Subdural Hematoma

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 2, 2024.

via HealthDay

MONDAY, Dec. 2, 2024 -- Middle meningeal artery embolization plus surgery is associated with a lower risk for hematoma recurrence or progression leading to reoperation than surgery alone among patients with symptomatic subacute or chronic subdural hematoma with an indication for surgical evacuation, according to a study published online in the Nov. 20 issue of the New England Journal of Medicine.

Jason M. Davies, M.D., Ph.D., from the University at Buffalo in New York, and colleagues conducted a prospective, interventional, adaptive-design trial involving patients with symptomatic subacute or chronic subdural hematoma with an indication for surgical evacuation. Patients were randomly assigned to undergo middle meningeal artery embolization plus surgery (treatment group; 197 patients) or surgery alone (control group; 203 patients).

Overall, 34.0 percent of the patients underwent surgery before being randomly assigned. The researchers found that hematoma recurrence or progression leading to repeat surgery occurred in 4.1 and 11.3 percent of patients in the treatment and control groups, respectively (relative risk, 0.36). Functional deterioration occurred in 11.9 percent of those in the treatment group and 9.8 percent in the control group. Mortality at 90 days was 5.1 and 3.0 percent in the treatment and control groups, respectively. Serious adverse events related to the embolization procedure had occurred in 2.0 percent of patients in the treatment group by 30 days; no additional events occurred by 180 days.

"The 90-day mortality appeared to be higher in the treatment group than in the control group (5.1 percent vs. 3.0 percent), but the difference was not attributed by independent assessors to the embolic agent or to the embolization procedure," the authors write.

Several authors disclosed ties to relevant organizations.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Overweight Status Appears to Reduce Mortality in Seniors Undergoing Elective Surgery

THURSDAY, Aug. 28, 2025 -- Older adults (aged 65 years and older) with overweight who undergo elective surgery have a lower rate of 30-day all-cause mortality compared with those...

Incidence of Hemodynamic Valve Deterioration 6.2 Percent After TAVI

TUESDAY, Aug. 26, 2025 -- For patients undergoing transcatheter aortic valve implantation (TAVI), the incidence of one-year hemodynamic valve deterioration (HVD) was 6.2 percent...

Broad Support Seen for Newly Developed Epilepsy Surgery Guideline

TUESDAY, Aug. 19, 2025 -- A newly developed epilepsy surgery educational curriculum has high support from neurosurgeons and neurologists, according to a report recently published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.